Review



cd80- pecy5  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher cd80- pecy5
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Cd80 Pecy5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/pmc06013321-175-37-44
    Average 90 stars, based on 1 article reviews
    cd80- pecy5 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses"

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses

    Journal: The Journal of allergy and clinical immunology

    doi: 10.1016/j.jaci.2017.10.044

    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of CD80 and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Figure Legend Snippet: A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of CD80 and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).

    Techniques Used: Derivative Assay, Flow Cytometry, Expressing, MANN-WHITNEY

    Related Articles

    Derivative Assay:

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses
    Article Snippet: Mouse DC subsets were identified and characterized by using anti- mouse Siglec F-PE-CF594, CD11c-APC Cy7, MHCII-PE Cy7, CD11b-PerCP Cy5.5, CD103- APC, PDCA1-AF488, Mar-1-efluor450, CD64-PE, TLR-4-APC, Dectin-1-PE, CD205- PerCPCy5.5, and CD206-BV785 antibodies, all from BioLegend (San Diego, CA); CD80- PECy5, CD86-605NC, and DC-SIGN-eFluor660 all from ThermoFisher Scientific, Waltham, MA); Dectin-2-AF647 (BioRad, Hercules, CA); and TLR 5-PE (Novus, Littleton, CO).

    Flow Cytometry:

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses
    Article Snippet: Mouse DC subsets were identified and characterized by using anti- mouse Siglec F-PE-CF594, CD11c-APC Cy7, MHCII-PE Cy7, CD11b-PerCP Cy5.5, CD103- APC, PDCA1-AF488, Mar-1-efluor450, CD64-PE, TLR-4-APC, Dectin-1-PE, CD205- PerCPCy5.5, and CD206-BV785 antibodies, all from BioLegend (San Diego, CA); CD80- PECy5, CD86-605NC, and DC-SIGN-eFluor660 all from ThermoFisher Scientific, Waltham, MA); Dectin-2-AF647 (BioRad, Hercules, CA); and TLR 5-PE (Novus, Littleton, CO).

    Expressing:

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses
    Article Snippet: Mouse DC subsets were identified and characterized by using anti- mouse Siglec F-PE-CF594, CD11c-APC Cy7, MHCII-PE Cy7, CD11b-PerCP Cy5.5, CD103- APC, PDCA1-AF488, Mar-1-efluor450, CD64-PE, TLR-4-APC, Dectin-1-PE, CD205- PerCPCy5.5, and CD206-BV785 antibodies, all from BioLegend (San Diego, CA); CD80- PECy5, CD86-605NC, and DC-SIGN-eFluor660 all from ThermoFisher Scientific, Waltham, MA); Dectin-2-AF647 (BioRad, Hercules, CA); and TLR 5-PE (Novus, Littleton, CO).

    MANN-WHITNEY:

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses
    Article Snippet: Mouse DC subsets were identified and characterized by using anti- mouse Siglec F-PE-CF594, CD11c-APC Cy7, MHCII-PE Cy7, CD11b-PerCP Cy5.5, CD103- APC, PDCA1-AF488, Mar-1-efluor450, CD64-PE, TLR-4-APC, Dectin-1-PE, CD205- PerCPCy5.5, and CD206-BV785 antibodies, all from BioLegend (San Diego, CA); CD80- PECy5, CD86-605NC, and DC-SIGN-eFluor660 all from ThermoFisher Scientific, Waltham, MA); Dectin-2-AF647 (BioRad, Hercules, CA); and TLR 5-PE (Novus, Littleton, CO).



    Similar Products

    90
    Thermo Fisher cd80- pecy5
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Cd80 Pecy5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/pmc06013321-175-37-44
    Average 90 stars, based on 1 article reviews
    cd80- pecy5 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Dakewe Biotech Co cd80-pecy5 antibody
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Cd80 Pecy5 Antibody, supplied by Dakewe Biotech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/fluorescence+labeled+antibodies+cd80+fitc/pmc12051126-240-31-32
    Average 90 stars, based on 1 article reviews
    cd80-pecy5 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher fitc-, pe- pecy5-conjugated antibodies against cd40, cd80, cd86, mhc ii
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Fitc , Pe Pecy5 Conjugated Antibodies Against Cd40, Cd80, Cd86, Mhc Ii, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/pmc03068158-182-49-54
    Average 90 stars, based on 1 article reviews
    fitc-, pe- pecy5-conjugated antibodies against cd40, cd80, cd86, mhc ii - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-cd80-pecy5
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Anti Cd80 Pecy5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/pe+cy5/pm34216770-112-8-11
    Average 90 stars, based on 1 article reviews
    anti-cd80-pecy5 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd80-pecy5 antibody
    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of <t>CD80</t> and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).
    Cd80 Pecy5 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/anti+cd80/10__1016_slash_j__jff__2020__103836-111-44-61
    Average 90 stars, based on 1 article reviews
    cd80-pecy5 antibody - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    R&D Systems cd80-pecy5
    Macrophage differentiation is enhanced by macrophage colony-stimulating factor (M-CSF) produced by IL-1β– or tumor necrosis factor (TNF)-α–treated first-trimester decidual cells (FTDCs). Peripheral monocytes were differentiated in conditioned medium [from FTDCs treated with control (EM; A), IL-1β (EMI; B) or TNF-α (EMT; C)] for 7 days with or without preincubation with an anti-human M-CSF antibody (D and E). Flow cytometric analysis assessed the expression of <t>CD80</t> (F and G) and CD163 on CD11b+ (H and I) macrophages. Arrows indicate cells with increased ruffles and pseudopods. Arrowheads indicate cells with fewer ruffles and pseudopods. Results are expressed as means ± SEM (F–I). n = 11 (F–I). ∗P < 0.05. Original magnification, ×400 (A–E). α-M, anti-M-CSF; Exp, expression.
    Cd80 Pecy5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/cd80+fc/pmc04861763-83-18-19
    Average 90 stars, based on 1 article reviews
    cd80-pecy5 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson pecy5-conjugated anti-human cd80 l307.1
    Macrophage differentiation is enhanced by macrophage colony-stimulating factor (M-CSF) produced by IL-1β– or tumor necrosis factor (TNF)-α–treated first-trimester decidual cells (FTDCs). Peripheral monocytes were differentiated in conditioned medium [from FTDCs treated with control (EM; A), IL-1β (EMI; B) or TNF-α (EMT; C)] for 7 days with or without preincubation with an anti-human M-CSF antibody (D and E). Flow cytometric analysis assessed the expression of <t>CD80</t> (F and G) and CD163 on CD11b+ (H and I) macrophages. Arrows indicate cells with increased ruffles and pseudopods. Arrowheads indicate cells with fewer ruffles and pseudopods. Results are expressed as means ± SEM (F–I). n = 11 (F–I). ∗P < 0.05. Original magnification, ×400 (A–E). α-M, anti-M-CSF; Exp, expression.
    Pecy5 Conjugated Anti Human Cd80 L307.1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd80-+pecy5/anti+cd80/pm24845157-68-15-16
    Average 90 stars, based on 1 article reviews
    pecy5-conjugated anti-human cd80 l307.1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of CD80 and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).

    Journal: The Journal of allergy and clinical immunology

    Article Title: LRP-1 Attenuates House Dust Mite-induced Eosinophilic Airway Inflammation by Suppressing Dendritic Cell-mediated Adaptive Immune Responses

    doi: 10.1016/j.jaci.2017.10.044

    Figure Lengend Snippet: A) The percentage of CD11c+/Siglec F−/MHC IIhi total lung DCs and B) the percentage of lung DC monocyte-derived dendritic cells (moDCs), conventional myeloid dendritic cells (cDCs), CD103+ DCs, and plasmacytoid dendritic cells (pDCs) subsets as quantified by flow cytometry (P = NS, HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice, n= 9 mice per group, unpaired t test). C) Cell surface expression of CD80 and CD86 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 8 – 9 mice per group, * P< 0.01, Mann-Whitney test). D) Cell surface expression of Dectin1, Dectin 2, CD205, CD206, and DC-SIGN by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n = 4 – 9 mice per group, * P = 0.029, Mann-Whitney test). E) Cell surface expression of TLR4 and TLR5 by lung CD11c+/CD11b+/SSClo/SiglecF−/MHC IIhi DCs from HDM-challenged Lrp1fl/fl; CD11c-Cre versus Lrp1fl/fl mice (n= 4 – 9 mice per group, *P < 0.05, unpaired t test).

    Article Snippet: Mouse DC subsets were identified and characterized by using anti- mouse Siglec F-PE-CF594, CD11c-APC Cy7, MHCII-PE Cy7, CD11b-PerCP Cy5.5, CD103- APC, PDCA1-AF488, Mar-1-efluor450, CD64-PE, TLR-4-APC, Dectin-1-PE, CD205- PerCPCy5.5, and CD206-BV785 antibodies, all from BioLegend (San Diego, CA); CD80- PECy5, CD86-605NC, and DC-SIGN-eFluor660 all from ThermoFisher Scientific, Waltham, MA); Dectin-2-AF647 (BioRad, Hercules, CA); and TLR 5-PE (Novus, Littleton, CO).

    Techniques: Derivative Assay, Flow Cytometry, Expressing, MANN-WHITNEY

    Macrophage differentiation is enhanced by macrophage colony-stimulating factor (M-CSF) produced by IL-1β– or tumor necrosis factor (TNF)-α–treated first-trimester decidual cells (FTDCs). Peripheral monocytes were differentiated in conditioned medium [from FTDCs treated with control (EM; A), IL-1β (EMI; B) or TNF-α (EMT; C)] for 7 days with or without preincubation with an anti-human M-CSF antibody (D and E). Flow cytometric analysis assessed the expression of CD80 (F and G) and CD163 on CD11b+ (H and I) macrophages. Arrows indicate cells with increased ruffles and pseudopods. Arrowheads indicate cells with fewer ruffles and pseudopods. Results are expressed as means ± SEM (F–I). n = 11 (F–I). ∗P < 0.05. Original magnification, ×400 (A–E). α-M, anti-M-CSF; Exp, expression.

    Journal: The American Journal of Pathology

    Article Title: Modulation of Decidual Macrophage Polarization by Macrophage Colony-Stimulating Factor Derived from First-Trimester Decidual Cells

    doi: 10.1016/j.ajpath.2015.12.021

    Figure Lengend Snippet: Macrophage differentiation is enhanced by macrophage colony-stimulating factor (M-CSF) produced by IL-1β– or tumor necrosis factor (TNF)-α–treated first-trimester decidual cells (FTDCs). Peripheral monocytes were differentiated in conditioned medium [from FTDCs treated with control (EM; A), IL-1β (EMI; B) or TNF-α (EMT; C)] for 7 days with or without preincubation with an anti-human M-CSF antibody (D and E). Flow cytometric analysis assessed the expression of CD80 (F and G) and CD163 on CD11b+ (H and I) macrophages. Arrows indicate cells with increased ruffles and pseudopods. Arrowheads indicate cells with fewer ruffles and pseudopods. Results are expressed as means ± SEM (F–I). n = 11 (F–I). ∗P < 0.05. Original magnification, ×400 (A–E). α-M, anti-M-CSF; Exp, expression.

    Article Snippet: Then, macrophages were harvested and blocked with normal human IgG followed by staining with anti-human CD11B-PE, CD163-APC, and CD80-PECy5 (R&D Systems), according to the manufacturer's instruction.

    Techniques: Produced, Expressing